Related references
Note: Only part of the references are listed.Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated With Neoadjuvant Therapy
Theodoros Michelakos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Cancer Stemness Meets Immunity: From Mechanism to Therapy
Peiwen Chen et al.
CELL REPORTS (2021)
CD9, a tetraspanin target for cancer therapy?
Aurelio Lorico et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2021)
Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells
Carmen Mota Reyes et al.
CLINICAL CANCER RESEARCH (2020)
Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma
Giampaolo Perri et al.
ANNALS OF SURGERY (2020)
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
Eva Versteijne et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update
Joseph A. Clara et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
The Evolutionary Origins of Recurrent Pancreatic Cancer
Hitomi Sakamoto et al.
CANCER DISCOVERY (2020)
The genomic landscape of recurrent pancreatic cancer is modified by treatment
Irene Y. Xie et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Chemotherapy and Tumor Evolution Shape Pancreatic Cancer Recurrence after Resection
Filip Bednar et al.
Cancer Discovery (2020)
The dormant cancer cell life cycle
Tri Giang Phan et al.
NATURE REVIEWS CANCER (2020)
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
Quisette P. Janssen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance
Maria Laura De Angelis et al.
FRONTIERS IN ONCOLOGY (2019)
CD9 identifies pancreatic cancer stem cells and modulates glutamine metabolism to fuel tumour growth
Victoria M. -Y. Wang et al.
NATURE CELL BIOLOGY (2019)
Exosomal markers (CD63 and CD9) expression and their prognostic significance using immunohistochemistry in patients with pancreatic ductal adenocarcinoma
Mohd Khushman et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)
Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma A Phase 2 Clinical Trial
Janet E. Murphy et al.
JAMA ONCOLOGY (2018)
Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells
Yu Shi et al.
CELL DEATH AND DIFFERENTIATION (2017)
Prognostic significance of CD9 expression differs between tumour cells and stromal immune cells, and depends on the molecular subtype of the invasive breast carcinoma
Hee Jung Kwon et al.
HISTOPATHOLOGY (2017)
Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells
Neza Podergajs et al.
ONCOTARGET (2016)
Cisplatin induces stemness in ovarian cancer
Andrew Wiechert et al.
ONCOTARGET (2016)
Downregulation of CD9 promotes pancreatic cancer growth and metastasis through upregulation of epidermal growth factor on the cell surface
Maochun Tang et al.
ONCOLOGY REPORTS (2015)
Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy
B. Auffinger et al.
CELL DEATH AND DIFFERENTIATION (2014)
DCLK1 Marks a Morphologically Distinct Subpopulation of Cells With Stem Cell Properties in Preinvasive Pancreatic Cancer
Jennifer M. Bailey et al.
GASTROENTEROLOGY (2014)
Tetraspanin proteins promote multiple cancer stages
Martin E. Hemler
NATURE REVIEWS CANCER (2014)
Neoadjuvant chemotherapy with gemcitabine for pancreatic cancer increases in situ expression of the apoptosis marker M30 and stem cell marker CD44
Hidehiro Tajima et al.
ONCOLOGY LETTERS (2012)
c-Met Is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target
Chenwei Li et al.
GASTROENTEROLOGY (2011)
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer
Patrick C. Hermann et al.
CELL STEM CELL (2007)
Identification of pancreatic cancer stem cells
Chenwei Li et al.
CANCER RESEARCH (2007)
Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach
M Gronborg et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
The tetraspanin CD9 is preferentially expressed on the human CD4+CD45RA+ naive T cell population and is involved in T cell activation
H Kobayashi et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Share Paper
